curriculum vitae - clalit · curriculum vitae name ilan leibovitch md 39095350-9 _____ (first)...
TRANSCRIPT
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
CURRICULUM VITAE
NAME ILAN LEIBOVITCH MD 39095350-9 __________________________________________________
(First) (Last) Academic Degree I.D No.
FACULTY/DEPT SACKLER FACULTY OF MEDICINE / SURGERY
HOSPITAL/DEPT MEIR MEDICAL CENTER KFAR SABA, DEPARTMENT OF UROLOGY
Tel: 09-7471557
EMAIL* [email protected] [email protected]
DATE AND PLACE OF BIRTH ISRAEL, 21ST
JANUARY 1956
ZAHAL (ISRAELI) MILITARY
SERVICE 1982 1987
(Enlisted) (Discharged)
MARITAL STATUS MARRIED + 4 CHILDREN
A.Education
PERIODS OF STUDIES
Hebrew University Hadassah School of Medicine Jerusalem, Israel (Name of University, City, Country) 1974-1980 (Period )
MEDICINE (Subject) M.D. November 1986
(Degree or Professional License ) (Date Awarded) Permanent Israeli Medical License No. 018880 April 1987 Degree or Professional license Date Awarded
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Late Complications in Combat Casualties (Title of Doctoral Dissertation) Ron R. Rozin M.D. and Joseph Klausner M.D
(Supervised by)
B. FURTHER STUDIES
Rokach Municipal Hospital, Tel Aviv Rotating Internship 1981 Name of University. City/country Subject Period Temporary Israeli Medical License Degree or Professional license January 1982 Date Awarded
Permanent Israeli Medical License No. 018880
Degree or Professional license
April 1987 Date Awarded
Sheba Medical Center Urology Residency 1987-1993 Name of University. City/country Subject Period Board Certificate License No. 12941 Degree or Professional license June 1993 Date Awarded
C. ACADEMIC & PROFESSIOMAL ACTIVITIES & ACHIEVEMENTS
C1. CLINICAL EXPERIENCE: 1981 Rotating Internship. Ichilov and Rokach Municipal
Hospitals, Tel Aviv. 1982-1984 Chief of Medical services in the School of
Armory. Israel Defence Force (ZAHAL).
1985-1986 Head of the department of Occupational Medical
Evaluation. Headquarters of Medical Corps, Israel Defence Force (ZAHAL).
November 1986-December 1988
Resident. Department of Surgery Hadassah-Rokach Municipal Hospital. Tel Aviv, Israel
. January 1989-June 1990 Resident.
Department of Urology The Chaim Sheba Medical Center Tel Hashomer. Israel.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
May 1990 Israeli Urology/Surgery Written Boards (part 1)
July 1990-December 1990 Scholar.
Department of Urology College of Physicians & Surgeons, Columbia University The Presbyterian Hospital, New York, N.Y. USA.
January 1991-March 1992 Resident.
The Department of Urology The Chaim Sheba Medical Center Tel Hashomer. Israel.
April 1992-March 1993 Chief Resident.
The Department of Urology The Chaim Sheba Medical Center Tel Hashomer. Israel
March 1993 Israeli Urology Oral Boards (part 2)
March 1993 – June 1993 Senior Urologist.
The Department of Urology The Chaim Sheba Medical Center Tel Hashomer. Israel
July 1993 – July 1995 Clinical Fellowship in Oncological Urology. The Deaprtment of Urology Indiana University Medical Center, Indianapolis, Indiana, USA. Under supervision of Prof. John P. Donohue
August 1995- Jan 2002 Senior Urologist,
The Department of Urology The Chaim Sheba Medical Center Tel Hashomer. Israel
May 1998 – Jan 2002 Chief of the Oncological Urology Service
The Department of Urology. The Chaim Sheba Medical Center Tel Hashomer. Israel
Since Feb 2002
Head of the Department of Urology Meir Medical Center Kfar Saba, ISRAEL
Since November 2012 Associate Professor of Surgery. Tel Aviv University, Sackler School of Medicine
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
C2. ACADEMIC EXPERIENCE
July 1990-December 1990 Scholar In the Molecular Biology Laboratories affiliated to the Department of Urology. College of Physicians & Surgeons, Columbia University. The Presbyterian Hospital, New York, N.Y. USA. Under supervision of Carl A. Olsson, M.D. and Ralph Buttyan PhD
November 1994 - July 1995 Research fellow.
In the CNS/GI/GU Eli Lilly research Laboratories. Eli Lilly Corporate Center, Indianapolis, Indiana, USA. Under supervision of Blake Lee Neubauer Ph.D.
1989 to date Teaching undergraduates in urology. Tel Aviv
University, Sackler School of Medicine 1995 to date Teaching postgraduates in radiology Tel Aviv
University, Sackler School of Medicine 1995 to date Teaching postgraduates in oncology Tel Aviv
University, Sackler School of Medicine 1995 to date Teaching postgraduates in emergency medicine
Tel Aviv University, Sackler School of Medicine Since October 1996 Principal Investigator CAPRxI study of
Early Prostate Cancer protocol 7054IL/0024 March 1998 Faculty of the European School of Oncology
post graduate and training course in Urological Cancer, Nicosia, Cyprus.
May 1998-March 2011 Member of the Israeli urology boards
committee. October 1998 – October 2000 Principal Investigator TULP study of intermittent
androgen deprivation protocol HOE 766U/3008
Since April 1999 Senior Lecturer of Surgery. Tel Aviv University,
Sackler School of Medicine
Since October 1999 Board member of CaP CURE Israel steering committee
January 2000 Organizing committee of the UICC prostate
cancer meeting. Eilat, Israel September 2000 Member of the Gynecomastia and Breast Pain
management workgroup (ASTRA ZENECA)
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
C3. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS
March 1988. 16th Annual Meeting of the Israel Surgical Society. Tel Aviv, Israel,
June 1989. 16th International Congress of Chemotherapy.
Jerusalem, Israel, November 1989. International College of Surgeons, 16th european
Federation Congress. Jerusalem, Israel. November 1989 Meeting of the Israel Urologic and Oncologic Society.
Petah-Tiqva, Israel,. April 1990. Israeli Pediatric Urology Meeting, Petah-Tiqva, Israel, June 1990. Meeting of the Israel Urologic and Oncologic Society.
Herzelia, Israel, April 1991 The 8th Congress of European Society for Urological
Oncology and Endocrinology. Marseille, France. April 1991 The Biennial Congress of the Israeli Urological
Society. Tiberias, Israel, June 1991 American Urological Association, 86th annual meeting,
Toronto, Canada, November 1991 Societe Internationale d'Urologie. 22nd Congress,
Sevilla, Spain May 1992 American Urological Association, 87th annual meeting,
Washington, DC. April 1993 The Biennial Congress of the Israeli Urological Society.
Haifa, Israel, May 1993 American Urological Association, 88th annual meeting,
San Antonio, Texas, May 1994 American Urological Association, 89th annual meeting,
San Francisco, California. May 1995 American Urological Association, 90th annual meeting,
Las Vegas, Nevada.
May 1996 American Urological Association, 91st annual meeting
Orlando, Florida. June 1996 The 16th meeting of the Israeli Urological Society. Eilat,
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Israel. September 1996 The 12th Congress of the European Association of
Urology, Paris, France. April 1997 American Urological Association, 92nd annual meeting,
New Orleans, USA. September 1997 24th World Congress, Societe Internationale
D’Urologie. Montreal, Canada. November 1997 The 17th meeting of the Israeli Urological Association.
Dead Sea, Israel. March 1998 The 13th Congress of the European Association of
Urology Barcelona, Spain. March 1998 European School of Oncology course in Urological
Cancer, Nicosia, Cyprus. June 1998 American Urological Association, 93rd annual meeting,
San Diego, USA. September 1998 Prostate Cancer Workshop. Cambridge, United
Kingdom November 1998 The 18th meeting of the Israeli Urological Association.,
Eilat, Israel. June 1999 2nd International consultation on prostate cancer Paris
France October 1999 Sixth CaP CURE Scientific Retreat Lake Tahoe, Nevada,
USA November 1999 The 19th meeting of the Israeli Urological Association.
Jerusalem, Israel. January 2000 UICC prostate cancer meeting. Eilat, Israel April 2000 The 15th Congress of the European Association of
Urology, Brussels, Belgium
May 2000 American Urological Association, 95th annual meeting, Atlanta, Georgia, USA.
September 2000 Seventh annual CaP CURE Scientific Retreat. Lake
Tahoe, Nevada, USA October 2000 25th World Congress, Societe Internationale
D’Urologie Singapore.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
November 2000 The 20th meeting of the Israeli Urological Association.
Eilat, Israel. March 2001 92nd annual meeting of the American Association for
cancer Research May 2001 37th annual meeting of the American Society of Clinical
Oncology. San Francisco, California, USA May 2001 22nd Annual Meeting of the Israel Surgical Society. Tel
Aviv, Israel, September 2001 Eighth annual CaP CURE Scientific Retreat. Lake
Tahoe, Nevada, USA November 2001 The 21st meeting of the Israeli Urological Association.
Eilat, Israel. November 2001 2nd European Perspectives on Bladder Cancer Monte
Carlo Monaco. June 2002 3rd International consultation on prostate cancer Paris
France September 2002 Ninth annual CaP CURE Scientific Retreat, Washington
DC USA November 2002 The 22nd meeting of the Israeli Urological Association.
Eilat, Israel November 2003 The 23rd meeting of the Israeli Urological Association.
Eilat, Israel November 2003 Tenth annual CaP CURE Scientific Retreat. New York
NY USA February 2004 The 4th World Congress On The Aging Male. Prague,
Czech Republic March 2004 The 19th Congress of the European Association of
Urology, Vienna. Austria June 2004 Androgen deficiency of the aging male. Tel Aviv, Israel July 2004 Urology in 2004: Today’s advances tommorow’s
clinical practice, London UK. August 2004 The inaugural ICR urology advisory board meeting,
Melbourne, Australia
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
August 2004 The 5th national prostate cancer and telerobotic
surgery symposium, Melbourne, Australia
September 2004 11th annual CaP CURE Scientific Retreat. Lake Tahoe,
Nevada, USA November 2004 The 24th meeting of the Israeli Urological Association.
Eilat, Israel January 2005 2nd Israeli Congress On The Aging Male Herzelia, Israel February 2005 ASCO Prostate Cancer Symposium Orlando Florida
USA May 2005 American Urological Association, 98th annual meeting,
San Antonio, Texas, USA June 2005 Prostate Cancer Summit, Athens, Greece. September 2005 12th annual prostate cancer foundation Scientific
Retreat. Scottsdale AZ, USA
November 2005
The 25th meeting of the Israeli Urological Association. Eilat, Israel
January 2006 3rd Israeli Congress On The Aging Male Herzelia, Israel February 2006 ASCO Prostate Cancer Symposium San Francisco CA
USA May 2006 American Urological Association, 99th annual meeting,
Atlanta, GA, USA June 2006 2nd congress of the Israeli society for sexual medicine
Tel Aviv, Israel October 2006 Improving clinical outcomes in genitourinary
malignancy a focus on prostate and renal cancer. ONE- Oncology Network Europe Monte Carlo, Monaco
October 2006 13th annual prostate cancer foundation Scientific
Retreat. Scottsdale AZ, USA November 2006 The 26th meeting of the Israeli Urological Association.
Eilat, Israel January 2007 4th Israeli Congress On The Aging Male Herzelia, Israel
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
February 2007 ASCO prostate cancer Symposium Orlando, FL, USA March 2007 The 22nd Congress of the European Association of
Urology. Berlin Germany September 2007 14th annual Prostate Cancer Foundation Scientific
Retreat. Lake Tahoe, Nevada, USA November 2007 The 27th meeting of the Israeli Urological Association.
Eilat, Israel February 2008 State of the Art BPH. Madrid, Spain. March 2008 ASCO Genitourinary cancers Symposium San
Francisco, CA, USA May 2008 American Urological Association, 101st annual
meeting, Orlando, FL, USA September 2008 15th annual Prostate Cancer Foundation Scientific
Retreat. Lake Tahoe, Nevada, USA March 2009 The 24th Congress of the European Association of
Urology, Stockholm. Sweden April 2009 American Urological Association, 102nd annual
meeting, Chicago, IL, USA June 2009 Master class metastatic renal cell carcinoma. Berlin,
Germany
October 2009 1st International Symposium on Hormonal Treatment Of Prostate Cancer (STOP-1) Athens , Greece.
November 2009 30th World Congress, Societe Internationale
D’Urologie Shanghai, China.
March 2010 ASCO Genitourinary Cancers Symposium San Francisco, CA, USA
November 2010 RCC EGM Medical Experts Forum New Delhi India
May 2011 American Urological Association, 104th annual
meeting, Washington DC, USA October 2011 3rd International Symposium on Hormonal Treatment
Of Prostate Cancer (STOP-3) Cannes, France.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
November 2012 EMUC 2012 – 4th European Multidisciplinary Meeting
on Urological Cancers March 2013 The 28nd Congress of the European Association of
Urology. Milan, Italy May 2013 American Urological Association, 106th annual
meeting, San Diego CA, USA December 2013 The 33rd meeting of the Israeli Urological Association.
Eilat, Israel October 2014 8th Prostate Cancer Debate Lisbon, Portugal November 2014 EMUC 2014 -- 6th European Multidisciplinary Meeting
on Urological Cancers Lisbon Portugal December 2014 The 34th meeting of the Israeli Urological Association.
Eilat, Israel
C4. MEMBERSHIP IN PROFESSIONAL SOCIETIES*
Years (period) Name of Organization
1981-present Israeli Medical Association.
1994-present Israeli Urological Association
1995-present American Urological Association.
1998-2000, 2013--- European urological association
November 2000 – November 2004
Secretary and Treasurer of the Israeli Urological Association
June 2005-november 2006 Comptroller of the Israeli Urological Association
November 2006-2007 Secretary of the Israeli Urological Association
December 2012---2014 President of the Israeli Urological Association
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
D. DOCTORAL STUDENTS MENTORED BY CANDIDATE*
Years (period)
Name of Student
Subject Academic Institute
Ph.D/ M.D
In collaboration with
E. M.A./M.Sc. Students :
Years (period) Name of Student
Subject Academic Institute
In collaboration with
F. Grants
Years
Investigator (Principal/,other)
Granted by Institute/Company
Total Amount
G. AWARDS
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
על פי ההנחיות
SCIENTIFIC PUBLICATIONS
A. BOOKS AND MONOGRAPHS
B. TEXTBOOKS (not for MDs)
B.1. ORIGINAL ARTICLES*
B.1. Articles Published
1.
.א. ליבוביץפ. גרייף, ע. בר, הכנה עצמית מהירה של שקופיות בעזרת המחשב.
1988 ,326-328 :115הרפואה. F. Grief, O. Bar, I. Leibovitch.
Rapid preparation of lecture slides by computer. Harefuah. 115: 326-8, 1988.
2. I. Leibovitch, J. Ramon, J. Ben Chaim, B. Goldwasser.
Increased urinary mucus production - a sequela of cystography following enterocystoplasty. J. Urol. 145: 736-7, 1991.
3. I. Leibovitch, J. Ben Chaim, J. Ramon, B. Goldwasser.
Increased serum alkaline phosphatase activity: A possible indicator of renal damage. J. Clin. Lab. Analysis 5: 406-9, 1991.
4. I. Leibovitch, R. Buttyan.
Hypothesis: Sulfatedglycoprotein-2 induced endogenous resistance to ischemia and reperfusion injury in the seminiferous tubules. Am. J. Reprod. Immunol. 26: 114-117, 1991.
5. I. Leibovitch, I. Avigad, O. Nativ, B. Goldwasser.
The frequency of histopathologic abnormalities in incidental appendectomy in urological patients. The implications for incorporation of the appendix in urinary tract reconstruction. J. Urol. 148: 41-43, 1992.
6. J. Ben Chaim, I. Leibovitch, J. Ramon, D. Weinberg, B. Goldwasser.
Etiology of acute scrotum at surgical exploration in children adolescents and adults. Eur. Urol. 21: 45-47, 1992.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
7.
, י. רמון, ב. גולדווסר.א. ליבוביץי. בן חיים, ג. רביב,
כפיתרון לאי שליטה בהטלת שתן. AS-800 תוצאות השתלת סוגר כיס שתן מלאכותי מדגם הרפואה. 1992 ,209-212 :122
J. Ben Chaim, G. Raviv, I. Leibovitch, J. Ramon, B. Goldwasser.
Artificial sphincter for urinary incontinence. Harefuah. 122: 209-12, 1992.
8. U. Martinowitz, D. Varon, P. Jonas, A. Bar Maor, B. Brenner, I. Leibovitch, M.
Heim. Circumcision in Hemophilia: The use of fibrin glue for local hemostasis. J. Urol. 148: 855-857, 1992.
9.
.א. ליבוביץב. גולדווסר, י. מור, ע. נתיב, חולים. 05סיכום ניסיון ב -כריתה רדיקלית של הערמונית
1992 ,509-512 :123 . הרפואה B. Goldwasser, Y. Mor, O. Nativ, I. Leibovitch.
Radical prostatectomy - experience with 50 patients. Harefuah. 123: 509-512, 1992.
10. I. Leibovitch, H. Hofman, B. Morag, J. Ben-Chaim, I. Avigad, B. Goldwasser. Vesicoureteral reflux and lower urinary tract injury. The possible role of suprapubic cystostomy. J. Urol. 149: 713-715, 1993.
11. G. Raviv, I. Leibovitch, J. Hanani, M. Hertz, B. Goldwasser, P. Jonas.
Hematuria and voiding disturbances caused by posterior urethral polyps. Diagnosis and management. Eur. Urol. 23: 382-385, 1993.
12. I. Leibovitch, J. Ben Chaim, J. Ramon, I. Madjar, IS. Engelberg, B.
Goldwasser. The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder: A clinical and pathological analysis. J. Surg. Oncol. 52: 31-35, 1993.
13. I. Leibovitch, I. Avigad, O. Nativ, J. Ben Chaim, B. Goldwasser.
Is it justified to avoid radical cystectomy in elderly patients with invasive transitional cell carcinoma of the bladder. Cancer. 71: 3098-3101, 1993.
14. B. Goldwasser, J. Ben Chaim, J. Golomb, I. Leibovitch, Y. Mor, I. Avigad.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Bladder neck closure with an Indiana stoma outlet - A technique for continent vesicostomy. Surg. Gynecol. Obstet. 177: 448-450, 1993.
15. G. Raviv, I. Leibovitch, Y. Mor, D. Nass, O. Medalia, M. Aronson, B.
Goldwasser, O. Nativ. Localized renal cell carcinoma treated by radical nephrectomy. Influence of pathologic data and importance of DNA ploidy pattern on disease outcome. Cancer. 72: 2207-2212, 1993.
16. I. Leibovitch, J. Ben Chaim, G. Raviv, Y. Mor, I. Avigad, B. Goldwasser.
Quantitative changes in platelet counts following major urological pelvic surgery. Eur. Urol. 24: 350-354, 1994.
17. I. Leibovitch, G. Raviv, J. Ben-Chaim, Y. Mor, I. Avigad, B. Goldwasser.
Pitfalls in the detection of urinary extravasation following major urinary tract reconstructive surgery. Urol. Int. 54: 70-73, 1995.
18. Y. Mor, B. Goldwasser, J. Ben Chaim, G. Raviv, I. Leibovitch, P. Jonas.
Upper pole heminephrectomy for duplex systems in children. A modified technical approach. Br. J. Urol. 73: 584-585, 1994.
19. R. Orvieto J. Alcalay, I. Leibovitch, H. Nehama,
Lack of association between varicocele and angiokeratoma of the scrotum (Fordyce). Military Med. 159: 523-524, 1994.
20. G. Raviv, I. Leibovitch, O. Shenfeld, Y. Mor, P. Jonas, B. Goldwasser.
Ureteropelvic junction obstruction: Relation of etiology and age of surgical repair to clinical outcome. Urol. Int. 52: 135-139, 1994.
21. O. Nativ, I. Shajrawi, I. Leibovitch, B. Moskovitz.
The malignant potential of postchemotherapy residual mature teratoma for disseminated nonseminomatous testicule tumors. Eur. Urol. 26: 216-218, 1994.
22. I. Leibovitch, RS. Foster, JL. Wass, RG. Rowland, R. Bihrle, JS. Little, KK.
Kopecky, JP. Donohue. Color doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphandenectomy and radical retropubic prostatectomy for prostatic carcinoma. J. Urol. 153: 1866-1869,1995
23. Y. Mor, I. Leibovitch, G. Raviv, D. Nass, O. Medalia, B. Goldwasser, O. Nativ.
Testicular seminoma: clinical significance of nuclear deoxyribonucleic acid ploidy pattern as studied by flow cytometry.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
J. Urol. 154: 1041-1044, 1995. 24. I. Leibovitch, RG. Rowland, B. Goldwasser, JP. Donohue.
Incidental appendectomy during urological surgery. J. Urol. 154: 1110-1112, 1995.
25. J. Baniel, I. Leibovitch, RS. Foster, RG. Rowland, R. Bihrle, JP. Donohue. Hyperamylasemia after postchemotherapy retroperitoneal lymph node dissection for testis cancer. J. Urol. 154:1373-1375, 1995.
26. P. Nash, I. Leibovitch, JP. Donohue.
Adrenalectomy via the dorsal approach: A benchmark for laparoscopic adrenalectomy. J. Urol. 154: 1652-1654, 1995.
27. I. Leibovitch, J. Baniel, RS. Foster, JP. Donohue.
The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer. J. Urol. 154: 935-939, 1995.
28. I. Leibovitch, RS. Foster, KK. Kopecky, JP. Donohue.
Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J. Urol. 154: 1759-1763, 1995.
29. I. Leibovitch, RS. Foster, TM. Ulbright, JP. Donohue.
Adult primry pure teratoma of the testis. The Indiana experience. a. Cancer. 75: 2244-2250, 1995.
b. The Year Book of Oncology. Edited by Simone JV. Mosby. St. Louis 1996. pp. 193-195.
30. I. Leibovitch, RG. Rowland, JS. Little, RS. Foster, R. Bihrle, JP. Donohue.
Cystography after radical retropubic prostatectomy: clinical implications of abnormal findings. Urology. 46: 78-80, 1995.
31. A. Coret, I. Leibovitch, Z. Heyman, Y. Mor, Y. Itzchak.
Ultrasonographic evaluation and clinical correlation of intratesticular lesions. A series of 39 cases. a. Br. J. Urol. 76: 216-219, 1995.
b. The Year Book of Oncology. Edited by Simone JV. Mosby. St. Louis 1996. pp. 187-188.
32. I. Leibovitch, G. Raviv, Y. Mor, O.Nativ, B. Goldwaser.
Reconsidering the necessity if ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma. Urology. 46: 316-320, 1996.
33. I. Leibovitch, M. Kaeffer, R. Bihrle.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
An alternative surgical technique for the management of afferent limb stricture in kock pouch continent urinary diversion. Urology. 46: 867-869, 1995.
34. Y. Mor , O. Shenfeld, I. Leibovitch, G. Raviv, O. Nativ, B. Goldwasser.
Radical prostatectomy - experience with 100 patients. Isr. J. Med. Sci. 31: 129-132, 1995
35. I. Leibovitch, P. Nash, RS Foster, JS. Little, JP. Donohue.
Spinal cord ischemia after post chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer.
J. Urol. 155: 947-951, 1996. 36. I. Leibovitch, JS. Little, RS. Foster, RG. Rowland, R. Bihrle, JP. Donohue.
Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors. J. Urol. 155: 952-954, 1996.
37. DM. Sutkowski, JE. Audia, RL. Goode, KC. Hsiao, I. Leibovitch, AM. McNulty,
BL. Neubauer. Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5a-reductase inhibitor. Prostate (Supplement) 6: 62-66, 1996.
38. I. Leibovitch, J. Baniel, RG. Rowland, ER. Smith Jr., JK Ludlow, JP. Donohue.
Malignant t esticuar neoplasms in immunosuppressed patients. J. Urol. 155: 1938-1942, 1996.
39. RS. Foster, J. Baniel, I. Leibovitch, M. Curran, R. Bihrle, RG. Rowland, JP.
Donohue. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.
J. Urol. 155: 1943-1945, 1996. 40. M. Kaefer, JE. Audia, N. Bruchovsky, RL. Goode, KC. Hsiao, I. Leibovitch, J.
Krushinski, DE. Lawhorn, C. Lee, CP. Steidle, DM. Sutkowski, BL. Neubauer. Characterization of Type I 5a-Reductase Activity in DU145 Human Prostatic Adenocarcinoma Cells. J. Steroid Biochem. Mol. Biol. 58: 195-205, 1996.
41. O. Nativ, Y. Mor, I. Leibovitch, S. Halachmi, B. Goldwasser. Transurethral hyperthermia for relieving obstructive vioding symptoms in
patients with hormone refractory prostate cancer. Isr. J. Med. Sci. 33: 182-185, 1997. 42. I. Leibovitch, RS. Foster, K. Kopecky, P. Albers, TM. Ulbright, JP. Donohue.
Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatis disease. A combined approach using quantitive immunohistochemical, histopathological and radiological assessmnet.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
a. J. Clin. Oncol. 16: 261-268, 1998. b. The Year Book of Oncology. Edited by Ozols RF. Mosby.
St. Louis 1998. pp. 42-44.
43. P. Nash, I. Leibovitch, RS. Foster, R. Bihrle, RG. Rowland, JP. Donohue. En bloc nephrectomy in patients undergoing post chemotherapy retroperitoneal
lymph node dissections for nonseminomatous testis cancer: Indications implication and outcomes. J. Urol. 159: 707-710, 1998.
44. A. Shalhav, I. Leibovitch, R. Lev, D. Hoenig, J. Ramon. Is laparascopic radical nephrectomy with specimen morcellation acceptable cancer surgery? J. Endourology 12: 255-257, 1998.
45. JP. Donohue, I. Leibovitch, RS. Foster, J. Baniel, P. Tognoni.
Integration of surgery and systemic therapy: Results and principles of integration. Sem. Urol. Oncol. 16:65-71, 1998.
46. J. Golomb, Z. Dotan, I. Leibovitch, Y. Mor, J. Ramon.
Can preoperative urodynamic examination allow us to predict the risk of incontinence after radical prostatectomy? Prog. Urol. .9:288-291, 1999.
47. ZA. Dotan, A. Dotan,T. Litmanovitch, Y. Ravia, N. Oniashvili, I. Leibovitch, J.
Ramon, L. Avivi. Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: a novel genetic alteration associated with malignancy. Genes Chromosomes Cancer 27:270-277, 2000. [oncology, rank 48/166 IF=3.858]
48. A. Vazina, J. Baniel, Y. Yaacobi, A. Shtriker, D. Engelstein, I. Leibovitch, M.
Zehavi, AA. Sidi, J. Ramon, T. Tischler, PM. Livne, E. Friedman. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate
cancer patients in Israel. Br. J. Cancer. 83:63-66, 2000. [oncology, rank 35/166 IF=4.346] 49. Y. Mor, I. Leibovitch, J. Golomb, J. Ramon. Routine cystoscopy before radical prostatectomy: is it justified? Urology 57:946-948, 2001. [urology&nephrology, rank 27/63 IF=2.365] 50. I. Leibovitch, R. Lev, Y. Mor, J. Golomb, ZA. Dotan, J. Ramon.
Extensive Necrosis in Renal Cell Carcinoma Specimens: Potential Clinical and Prognostic Implications IMAJ 3: 1-3, 2001 [medicine general&internal, rank 81/133 IF=0.898]
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
51. Dotan Z, Mor Y, Leibovitch I, Varon D, Golomb J, Duvdevani M, Ramon J. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol.;168: 610-3, 2002 [urology&nephrology, rank 8/63 IF=4.016]
52. Gygi CM, Leibovitch I, Adlington R, Baldwin JE, Chen B, Mccoull W, Pritchard GJ, Becker GW, Dixon EP, Little SP, Sutkowski DM, Teater C, Neubauer BL.
Prostate-specific antigen (PSA)-mediated proliferation, androgenic regulation and inhibitory effects of LY312340 in HOS-TE85 (TE85) human osteosarcoma cells. Anticancer Res. 22: 2725-32. 2002 [oncology, rank 126/166 IF=1.428]
54. Golomb J, Leibovitch I, Mor Y, Morag B, Ramon J. Comparison of voiding cystourethrography and double-balloon urethrography
in the diagnosis of complex female urethral diverticula. Eur Radiol. 13: 536-42. 2003 [radiology&imaging, rank 13/104 IF=3.589] 55. I. Leibovitch, D. Gillat, P. Hopwood, P. Iversen, B. Mansel, D. McLeod, V.
Navarette, P. Richaud, W. See, C. Tyrrell, M. Wirth. Management options for gynaecomastia and breast pain associated with nonsteroidal antiandrogen therapy: case studies in context.
Clinical Drug Investigation 23: 205-215, 2003. [pharmacology, rank 168/237 IF=1.414]
56. Mor Y, Leibovitch I, Zalts R, Lotan D, Jonas P, Ramon J.
Analysis of the long-term outcome of surgically corrected vesico-ureteric reflux. BJU Int. 92, 97-100. 2003 [urology &nephrology rank 15/63 IF=2.865]
57. Mor Y, Leibovitch I, Fridmans A, Farkas A, Jonas P, Ramon J. Late post-reimplantation ureteral obstruction during pregnancy: a transient phenomenon?
J Urol. 170(3): 845-8. 2003. [urology&nephrology, rank 8/63 IF=4.016] 58. Mor Y, Leibovitch I, Golomb J, Ben Caim J, Nadu A, Pinthus JH, Ramon J. Reconstruction du bas appareil urinaire par entérocystoplastie
d’agrandissement et mise en place isolée d’une manchette de sphincter artificial. [Lower urinary tract reconstruction by augmentation cystoplasty and insertion of artificial urinary sphincter cuff only: long term follow-up] Progrés en Urologie. 14: 310-314, 2004. . [urology &nephrology rank 53/63 IF=0.611]
59. Pinthus JH, Oksman Y, Leibovitch I, Goshen E, Dotan ZA, Schwartz A, Ramon
J, Zwas ST, Mor Y. The role of indirect radionuclide cystography during the acute phase of pyelonephritis in young women.
BJU Int. 95: 619-23, 2005. [urology &nephrology rank 15/63 IF=2.865]
60. Jacobson O, Bechor Y, Icar A, Novak N, Birman A, Marom H, Fadeeva L,
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Golan E, Leibovitch I, Gutman M, Even-Sapir E, Chisin R, Gozin M, Mishani Prostate cancer PET bioprobes: Synthesis of [(18)F]-radiolabeled hydroxyflutamide derivatives.
Bioorg Med Chem. 13: 6195-205, 2005. [medicinal chemistry, rank 17/46 IF=2.822]
61. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L,Zilberstien Y, Friberger A,
Kidron D,M Kaplan E, Lew S, Leibovitch I. Combined analysis of morphology and fish significantly increases the accuracy of bladder cancer detection in voided urine samples. Urology 66: 1354-59 2005 [urology&nephrology, rank 27/63 IF=2.365]
62. Vainrib M, Zelokovsky E, Erlich N, Eidelberg I, Kaneti J, Leibovitch I. Epidemiology of Transitional Cell Carcinoma among Israeli Arabs Harefua 145: 18-21 2006
63. Leibovitch I, Pinthus Y, Sella BA, Ramon J
Plasma chromogranin-A )CgA ) a potential marker for diagnosis,
monitoring and management of prostate cancer patients. Harefua 145: 25-9, 2006
64. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT. J NucL Med 47: 287-297, 2006 [radiology&imaging, rank 1/104 IF=6.424]
65. Jacobson O, Laky D, Carlson KE, Elgavish S, Gozin M, Even-Sapir E, Leibovitch I, Gutman M, Chisin R, Katzenellenbogen JA, Mishani E. Chiral dimethylamine flutamide derivatives--modeling, synthesis, androgen receptor affinities and carbon-11 labeling. Nucl Med Biol. 33: 695-704. 2006. [radiology&imaging, rank 35/104 IF=2.456]
66. Golomb J, Leibovitch I, Mor Y, Nadu A, Ramon J.
Fascial patch technique for repair of complicated urethrovaginal fistula. Urology 68: 1115-1118. 2006. [urology&nephrology, rank 27/63 IF=2.365]
67. Zohar E, Noga Y, Rislick U, Leibovitch I, Fredman B.
Intrathecal anesthesia for elderly patients undergoing short transurethral procedures: a dose-finding study. Anesth Analg. 104: 552-4. 2007. [anesthesiology, rank 6/25 IF=3.083]
68. Shefler A, Veinrib M, Tikochinski G, Shalev M, Santiago R, Leibovitch I.
The role of conservative management in penetrating renal trauma. Harefuah. 146: 345-348, 2007.
69. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S,
Leibovitch I.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Cancer Cytopathology. 111: 517–24, 2007. [oncology, rank 69/166 IF=2.768]
70. Vainrib M, Leibovitch I.
Urological implications of concurrent bladder and lung cancer. Isr Med Assoc J. 9: 732-5, 2007. [medicine general&internal, rank
18/133 IF=0.898]
71. Agemy L, Harmelin A, Waks T, Leibovitch I, Rabin T, Pfeffer MR, Eshhar
Z. Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts. Prostate. 2008 Apr 1;68(5):530-9. [urology&nephrology, rank 14/63 IF=3.081]
72. Sidi AA, Ohana P, Benjamin S, Shalev M, Ransom JH, Lamm D, Hochberg A,
Leibovitch I. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 overexpressing superficial bladder cancer refractory to BCG J Urol. 2008;180(6):2379-83. [urology&nephrology, rank 8/63 IF=4.016]
73. Nativ O, Witjes JA, Hendricksen K, Cohen M, Kedar D, Sidi A, Colombo R, Leibovitch I. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin. J Urol. 2009, 182(4):1313-7 [urology&nephrology, rank 8/63 IF=4.016]
74. Sternberg I, Rona R, Olsfanger S, Lew S, Leibovitch I. The clinical significance of class III (suspicious) urine cytology.
Cytopathology 2011, 22(5): 329-33. [pathology, rank 48/71 IF=1.349]
75. Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, Colombo R.
The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review. Eur Urol. 2011, 60(1):81-93. [urology&nephrology, rank 2/63 IF=7.667]
76. Laufer M, Keller T, Gershman V, Ferman Z, Sarid M, Leibovitch I. InoPro
trial: collaboration between urologists and primary care physicians in the treatment of osteoporosis in prostate cancer patients. Harefuah. 2014 153(3-4):151-4
77. Gofrit ON, Benjamin S, Halachmi S, Leibovitch I, Dotan Z, Lamm DL, Ehrlich N, Yutkin V, Ben-Am M, Hochberg A. DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer. J Urol. 2014;191(6):1697-702 [urology&nephrology, rank 9/76 IF=4.471]
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
78. Ron R, Zbaida D, Kafka IZ, Rosentsveig R, Leibovitch I, Tenne R. Attenuation of encrustation by self-assembled inorganic fullerene-like nanoparticles. Nanoscale. 2014 ;6(10):5251-9. [Nanoscience & Nanotechnology rank 12/94 IF=7.934]
B.1. Articles Accepted
B.1. Articles Submitted
1. I. Leibovtich, J. Witjes,. K Hendricksen,. M. Cohen,. D. Keidar, A. Sidi,. R. Colombo, O Nativ Ablative combined thermo-chemotherapy for the management of patients with superficial bladder cancer unamenable for complete TUR J Urol
B.2. CASE REPORTS
B.2. Case Reports published
1.
, ש. ללצוק, ע. קפלן, ר. רוזין.א. ליבוביץ Dieulafoyדמם מסכן חיים מנגע
1989 ,304-305 :117 הרפואה. I. Leibovitch, S. Lelcuk, O. Kaplan, RR. Rozin.
Dieulafoy's lesion. Harefuah. 117: 304-5, 1989.
2. S. Lelcuk, I. Leibovitch, O. Kaplan, RR. Rozin.
Stomach rupture caused by false intubation of the esophagus. Isr. J. Med. Sci. 26: 167-8, 1990.
3. I. Leibovitch, M. Gutman, Y. Skornick, RR. Rozin.
Giant inguinoscrotal hernia ensuing fatal complications. Isr. J. Med. Sci. 26: 408-10, 1990.
4.
, י. רמון, י. בן חיים, ב. גולדווסר.א. ליבוביץ
התנקבות עצמונית מאוחרת של כיס שתן לאחר ניתוח הגדלה באמצעות חלקי מעי. 1990 ,68-70 :119. הרפואה
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
I. Leibovitch, J. Ramon, J. Ben Chaim, B. Goldwasser. Spontaneous rupture of the bladder after augmentation cystoplasty. Harefuah. 119: 68-70, 1990.
5. I. Leibovitch, J. Ramon, J. Ben Chaim, D. Nass, B. Goldwasser.
Chronic hematocele complicating renal failure and hemodialysis. J. Urol. 146: 162, 1991.
6.
קלביר, פ. יונש. , י. גולומב, ס.א. ליבוביץי. מור, הגישה לתסביב האשך בילוד.
1992 ,167-168 :123. הרפואה Y. Mor, I. Leibovitch, J. Golomb, S. Klavir, P. Jonas.
The management of neonatal testicular torsion. Harefuah. 123: 167-168, 1992
7. J. Ben-Chaim, I. Leibovitch, G. Raviv, Y. Mor, B. Goldwasser.
Persistent vasocutaneous fistula associated with urinary Mycobacterium Chelonaei Infection. J. Urol. 149: 140-141, 1993.
8. B. Goldwasser, I. Leibovitch, I. Avigad.
Ureteral substitution using the isolated interposed vermiform appendix in a patient with a single kidney and transitional cell carcinoma of the ureter. Urology. 44: 437-440, 1994
9. I. Leibovitch, Z. Heyman, J. Ben Chaim, B. Goldwasser.
Ultrasonographic detection and control of eosinophilic cystitis. Abdom. Imaging. 19: 270-271, 1994.
10. Y. Servadio, I. Leibovitch, S. Apter, Y. Mor, B. Goldwasser.
Symptomatic heterotropic splenic tissue in the left renal fossa. Eur. Urol. 25: 174-176, 1994.
11. I. Leibovitch, K. Westenfelder, J. Vaught, RG. Rowland.
Orthostatic abnormal penile erections: consequence of retroperitoneal lymphadenectomy with vena caval resection. J. Urol. 154: 533-534, 1995.
12. O. Nativ, Y. Mor, D. Nass, I. Leibovitch, B. Goldwasser.
Cholesterol granuloma of the tunica vaginalis mimicking a neoplasm. Isr. J. Med. Sci. 31: 235-236, 1995.
13. Y. Mor, I. Leibovitch, A. Gerniak, I. Avigad, P. Jonas, B. Goldwasser.
Pseudomyxoma extraperitonei: An unusual presentation mimicking a huge hydronephrotic kidney.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Clin. Radiol. 51: 221-222, 1996.
14 ZA. Dotan, Y. Mor, D. Olchovsky, S. Aviel-Ronen, S. Engelberg, J. Pinthus, S. Shefi, I. Leibovitch, J. Ramon. Solitary fibrous tumor presenting as perirenal mass associated with hypoglycemia. J. Urol. 62:2087-2088, 1999. urology&nephrology, rank 8/63 IF=4.016]
15. R. Lev, Y. Mor, J. Golomb, I. Leibovitch, J. Ramon. Missed female urethral injury complicated by myonecrosis of the thigh. J. Urol. 165:1216, 2001. urology&nephrology, rank 8/63 IF=4.016] 16. J. Golomb, A. Groutz, Y. Mor, I. Leibovitch, J. Ramon.
Management of urethral erosion caused by a pubovaginal fascial sling. Urology 57:159-160, 2001. [urology&nephrology, rank 27/63 IF=2.365]
17. Duvdevani M, Nass D, Neumann Y, Leibovitch I, Ramon J, Mor Y. Pure rhabdoid tumor of the bladder. J Urol. 166: 2337, 2001 urology&nephrology, rank 8/63 IF=4.016]]
18. Lev R, Mor Y, Leibovitch I, Golomb J, Perelman M, Heyman Z, Ramon J. Epidermoid cyst of the testis in an adolescent: Case report and review of the evolution of the surgical management. J Pediatr Surg. 37: 121-3. 2002 [pediatrics, rank 47/94 IF=1.430]
19. Leibovitch I, Mor Y, Golomb J, Ramon J.
Chylous ascites after radical nephrectomy and inferior vena cava thrombectomy. Successful conservative management with somatostatin analogue. Eur Urol. 41: 220-2. 2002 [urology &nephrology rank 2/63 IF=7.667]
20. Gayer G, Mini S, Olchovsky D, Leibovitch I, Apter S, Weitzen R, Hertz M. Pulmonary embolism-the initial manifestation of renal cell carcinoma in a young woman. Emerg Radiol. 10(1): 43-5, 2003.
Mor Y, Leibovitch I, Duvdevani M, Jacobson J, Fridman E, Ramon J. Scrotal epidermal inclusion cyst clinically mimicking polyorchidism in a child: ultrasonic characteristics. Pediatr Radiol. 34(2): 175-6. 2004. [radiology&imaging, rank 73/104 IF=1.186]
Mor Y, Leibovitch I, Sherr-Lurie N, Golomb J, Jonas P, Ramon J. Traumatic female urethral injury: an overlooked entity. Isr Med Assoc J. 6: 634-5, 2004. [medicine general&internal, rank 81/133 IF=0.898]
21. Leibovitch I, Veinreb M, Sterenberg I, Alkalay R.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Prosthetic valvular hemolysis: a potential pitfall in the routine use of serum lactate dehydrogenase as tumor marker in patients with germ cell testicular tumors. Isr Med Assoc J. 8: 659-60. 2006. [medicine general&internal, rank 81/133 IF=0.898]
B.2. Case Reports Accepted
B.2. Case Reports Submitted
B.3. REVIEW ARTICLES
B.3. Review Articles Published
1. I. Leibovitch, B. Goldwasser. The spectrum of Acquired immune deficiency syndrome - associated testicular disorders.
Urology. 44: 818-824, 1994. 2. Y. Mor, I. Keidan, I. Leibovitch, J. Ramon.
Latex allergy as a life-threatening danger in children: importance of increased awareness of this phenomenon Harefuah138:498-501, 2000.
3. Leibovitch I, Mor Y, Golomb J, Ramon J.
The diagnosis and management of postoperative chylous ascites. J Urol. 167: 449-57, 2002. [urology&nephrology, rank 8/63 IF=4.016]
4. Leibovitch I. Postoperative chylous ascites--the urologist's view.
Drugs Today (Barc). 38 :687-97, 2002.
5. Leibovitch I, Mor Y.
The vicious cycling: bicycling related urogenital disorders. Eur Urol. ;47: 277-86, 2005 [urology &nephrology rank 2/63 IF=7.667]
B.3. Review Articles Accepted
B.3. Review Articles Submitted for Publication
C. CHAPTERS IN BOOKS
1. J. Ramon, B. Goldwasser, I. Leibovitch. Bladder replacement using the detubularized right colon.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
In: Orthotopic bladder replacement. Indications techniques and results. Edited by E. Alcini and A. D’Addessi. Universita’ Catholica Del S Cuore. Rome 1991, pp.55-62.
2. J. Ramon, I. Leibovitch, B. Goldwasser.
Implications of use of bowel segments in reconstructive urology. In: Reconstructive Urology, Edited by G. Webster, R. Kirby. L. King, B. Goldwasser. Blackwell Scientific Publications. Boston 1993. Vol. 1. Chapter 14. pp 189-202.
D.1.INVITED PAPERS IN SCIENTIFIC MEETINGS
D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS
1. S. Lelcuk, I. Leibovitch, Y. Igra, O. Kaplan, R. Rozin. Prophylactic antibiotic treatment in staged surgery for breast cancer. Proceedings of the 16th International Congress of Chemotherapy, pp. 656.1-2, June 1989 Israel,
D.3. ABSTRACTS
1. I. Leibovitch, CA. Olsson, B. Goldwasser, R. Buttyan.
A novel multidrug resistance-1 related product synthesized exclusively during the regression of the rat ventral prostate gland. J. Urol. 145: 293A, Abstract 322, 1991.
2. K. Slawin, I. Leibovitch, CA. Olsson, R. Buttyan.
Genetic manipulation of the mouse prostate gland. J. Urol. 145: 348A, Abstract 542, 1991.
3. I. Leibovitch, B. Goldwasser.
The frequency of histo pathologic abnormalities in incidental appendectomy in urological patients. The implications for incorporation of the appendix in urinary tract reconstruction. J. Urol. 147: 301A, Abstract 353, 1992.
4. K. Slawin, M. Kolombel, I. Leibovitch, CA, Olsson, R. Buttyan.
Transgenic studies: Evidence that a prostate specific promotor acts by silencing inappropriate expression sites. J. Urol. 147: 319A, Abstract 425, 1992.
5. I. Madjar, I. Leibovitch, J. Ben Chaim, O. Nativ, B. Goldwasser.
Is it justified to avoid radical cystectomy in elderly patients with invasive transitional cell carcinoma of the bladder. J. Urol. 147: 402A, Abstract 757, 1992.
6. I. Leibovitch, J. Ben Chaim, I. Madjar, B. Goldwasser.
The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder: A clinical and pathological analysis. J. Urol. 147: 445A, Abstract 932, 1992.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
7. J. Hanani, I. Leibovitch, A. Korat, Y. Vardi B. Goldwasser.
Assessment of hemodynamic response of the glans penis following intracorporeal injection. J. Urol. 149: 345A, Abstract 531, 1993.
8. J. Hanani, I. Leibovitch, B. Goldwasser.
Intracorporealthree drug combination treatment in erectile dysfunction. Comparison to papaverine-phentolamine and prostaglandin E1 alone. J. Urol. 149: 345A, Abstract 530, 1993.
9. I. Leibovitch, G. Raviv, Y. Mor, O. Nativ, B. Goldwasser.
Reconsidering the concept of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma. J. Urol. 149: 444A, Abstract 924, 1993.
10. Y. Mor, I. Leibovitch, G. Raviv, D. Nass, B. Goldwasser, O. Nativ.
Testicular seminoma. Clinical significance of nuclear DNA ploidy pattern as studied by flow cytometry. J. Urol. 149: 310A, Abstract 389, 1993.
11. G. Raviv, I. Leibovitch, Y. Mor, D. Nass, O. Medalia, M. Aronson, B.
Goldwasser, O. Nativ. Long term influence of nuclear DNA ploidy pattern in patients with localized renal cell carcinoma treated by radical nephrectomy. J. Urol. 149: 443A, Abstract 923, 1993.
12. O. Nativ, O. Medalia, G. Raviv, Y. Mor, I. Leibovitch, SI. Engelberg, M.
Aronson. Enhanced cytologic detection of early stage bladder cancer following intravesical instillation of bacterial endotoxin. J. Urol. 149: 240A, Abstract 108, 1993.
13. I. Leibovitch, RG. Rowland, JP. Donohue, B. Goldwasser.
The controversy of incidental appendectomy in urological patients. J. Urol. 151: 242A, Abstract 57, 1994.
14. I. Leibovitch, RS. Foster, JP. Donohue.
Adult primry pure teratoma of the testis. The Indiana experience. J. Urol. 153: 425A, Abstract 785, 1995.
15. RS. Foster, I. Leibovitch, RG. Rowland, R. Bihrle, JP. Donohue.
Postchemotherapy germ cell retrocrural tumor: Surgical approach and tissue analysis. J. Urol. 153: 424A, Abstract 784, 1995.
16. I. Leibovitch, RS. Foster, KK. Kopecky, JP. Donohue.
Is it possible to categorically define the “normal” abdominal computed tomography in patients with low stage nonseminomatous germ cell cancer? J. Urol. 153: 424A, Abstract 783, 1995.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
17. CM. Gygi, I. Leibovitch, RL. Goode, EP. Dixon, SP. Little, DM. Sutkowski, BL. Neubauer. Androgen-dependent Expression and Stimulation of Proliferation in HOS-TE85 (HOS) Human Osteoblastic Osteosarcoma Cells by prostate-specific antigen (PSA). J. Urol. 155: 340A (abstract 117), 1996.
18. I. Leibovitch, RS. Foster, KK. Kopecky, P. Albers, TM. Ulbright, JP. Donohue.
Identification of clinical stage A NSGCT patients at extremely low risk for metastatic disease. A combined approach using quantitive immunohistochemical, histopathological and radiological assessment. J. Urol. 155: 327A (abstract 68), 1996. .
19. J. Baniel, RS. Foster, I. Leibovitch, JP. Donohue. Secondary retroperitoneal lymphadenectomy (RPLND) in the management of recurrent germ cell testis tumors.
J. Urol. 155: 548A (abstract 948), 1996. .
20. Z. Dotan, J. Golomb, O. Shenfeld, I. Leibovitch, J. Ramon. can preoperative urodynamicstudies predict the continence status following radical prostatectomy.
J. Urol. 155: 395A (abstract 337), 1996. 21. JP. Donohue, RS. Foster, I. Leibovitch, R. Bihrle, RG. Rowland, GR. Wahle, L. Einhorn. Retroperitoneal lymph node dissection for post chemotherapy residual masses (PCRPLND) in patients with advanced testis cancer. Review of the Indiana experience 1974-1994.
J. Urol. 155: 327A (abstract 66), 1996. 22. A. Shalhav, I. Leibovitch, R. Lev, J. Ramon.
Is laparascopic nephrectomy with specimen morcellation acceptable cancer surgery?
J. Endourology. 10 (Suppl. 1): S138, (abstract P10-319), 1996. 23. J. Golomb, J. Pinthous, J. Benchaim, A. Shalhav, O. Shenfeld, L. Agulanski, I. Leibovitch. Quality of life survey in patients undergoing bladder neck suspension
compared to anterior colporaphy. J. Urol. 157:456 (abstract 1784), 1997. 24. R. Lev, I. Leibovitch, J. Ramon. Incidence and significance of extensive necrosis found in renal cell carcinoma
specimens. Br. J. Urol. 80 (suppl. 2): 138, (abstract 539), 1997. 25. J. Ramon, A. Shalhav, O. Shenfeld, I. Leibovitch. Over than one year follow-up of patients undergoing TUNA. Br. J. Urol. 80 (suppl. 2): 150, (abstract 734), 1997.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
26. Y. Mor, I. Leibovitch, J. Ramon. Routine cystoscopy prior to radical prostatectomy. Is it justified? Br. J. Urol. 80 (suppl. 2): 262, (abstract 1029), 1997. . 27. J. Baniel, RS. Foster, I. Leibovitch, JP Donohue. Secondary retroperitoneal lymphnode dissection in the management of
recurrent germ cell testicular tumors. Br. J. Urol. 80 (suppl. 2): 291, (abstract 1142), 1997. 28. I. Leibovitch, A. Koret, Z. Heyman, J. Baniel. J. Ramon. Routine ultrasonographic screening of the remaining testis after radical orchiectomy for germ cell testis tumor. Br. J. Urol. 80 (suppl. 2): 291, (abstract 1143), 1997. 29. J. Golomb, Z. Dotan R. Heiruti, N. Blumen, J. Pinthus, I. Leibovitch, J. Ramon The role of ice water test (IWT) in the evaluation of involuntary detrusor
contractions. Eur. Urol. 33 (suppl 1): 9, (abstract 36), 1998.
30. J. Pinthus, I. Leibovitch, E. Atar, B. Morag, Z. Dotan, J. Ramon. Ureterointestinal implantation in orthotopic neobladders. Comparison of
different antireflux techniques.
Eur. Urol. 33 (suppl 1): 18, (abstract 72), 1998.
31. Z. Dotan, J. Golomb, I. Leibovitch, J. Pinthus, Z. Minski, J. Ramon. Videourodynamic evaluation in patients following orthotopic neobladder
replacement. Long term results.
Eur. Urol. 33 (suppl 1): 66, (abstract 264), 1998.
32. J. Pinthus, I. Leibovitch, Z. Dotan, Y. Mor, J. Golomb, J. Ramon. Augmentation enterocystoplasty: single institution experience.
Eur. Urol. 33 (suppl 1): 96, (abstract 381), 1998.
33. I. Madgar, G. Raviv, J. Ramon, I. Leibovitch, R. Weissenberg, Y. Menashe, J. Levron, S. Mashiach, J. Dor.
Do testicular histology and clinical characteristics predict sperm detection in
azoospermic men during sperm retrieval (TSR).
J. Urol. 159 (suppl) : 210, (abstract 812 ), 1998.
34. ZA. Dotan, T. Litmanovitch, A Dotan, Y. Ravia,.N. Oniashvili, I. Leibovitch, J. Ramon, L. Avivi. Allele-specific mode of replication in lymphocytes of cancer patients with solid tumors: A new aspect of genome instability.
Am. J. Hum. Genet 63: A132 (supplament). (abstract 738) 1998.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
35. I. Leibovitch, J. Ramon, Z. Hayman, J. Baniel, P. Livne, Y. Vardi, O. Nativ, S. Meretik.
Annual Ultrasonographic (US) Screening of the Remaining Testis Following Unilateral Radical Orchiectomy for Testicular Germ Cell Tumor (GCT). A Prospective Multicenter Study. J. Urol. 161: (suppl) 183 (abstract 708), 1999.
36. ZA. Dotan, A. Dotan, T. Litmanovitch, Y. Ravia, N. Oniashvili, I. Leibovitch, J.
Ramon, L. Avivi; Allele-Specific Mode of Replication of Peripheral Lymphocytes from Renal Cell Carcinoma (RCC) Patients: A New Aspect of Genomic Instability
J. Urol. 161: (suppl) 141 (abstract 538), 1999.
37. A.Vazina, J. Baniel, A. Shtriker, D. Engelstein, I. Leibovitch, M. Zehavi, T.
Tishler, PM. Livne, E. Friedman The Prevalence of the Major “Jewish Mutations” BRCA1 and BRCA2 in
Prostate Cancer Patients in Israel J. Urol. 161: (suppl) 55 (abstract 206), 1999.
38. JH. Pinthus, Z. Gavish, J. Ramon, I. Leibovitch, Z. Esshar, M. Pines
Oral halofuginone prevents the growth of human prostate cancer in scid mice.
J. Urol. 163: (suppl) (abstract 146), 2000.
39. I. Leibovitch, Z. Dotan, Y. Mor, J. Ramon.
Testicular cancer diagnosed above the age of 50 years.
J. Urol. 163: (suppl) (abstract 648), 2000.
40. I. Leibovitch, Y. Mor, Z. Dotan, A. Gerniak, B. Morag, J. Ramon.
Percutaneous CT guided biopsy as an adjunctive measure in the evaluation of renal masses. Br. J. Urol. International. 86:165, Suppl 3, abstract P4.4.07, 2000.
41. I. Leibovitch, ZA. Dotan, RS. Foster, JP. Donohue Y. Mor, J. Ramon.
A seasonal cycle in the occurrence of newly diagnosed testicular cancer cases.
Br. J. Urol. International. 86:161, (Suppl 3), abstract P4.3.19, 2000.
42. I. Leibovitch, Y. Mor, ZA. Dotan, J. Ramon
High dose bicalutamide for hormone refractory prostate cancer.
Br. J. Urol. International. 86:57, Suppl 3, abstract P2.1.17, 2000
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
43. O. Nativ, E. Sabo, A. Lanir, M. Wald, B. Moskovitz, I. Leibovitch, G. Raviv, J. Ramon Percent free prostate-specific antigen density: a new variable for better differentiation of prostate cancer from benign prostatic enlargement.
Br. J. Urol. International. 86:101, Suppl 3, abstract P3.1.03, 2000.
44. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases by 99mTc-MDP planar bone scintigraphy, ingle and multi- field-of-views SPECT, 18F-fluoride PET and 18F-fluoride PET-CT. Prospective study in 44 patients with high-risk prostate cancer. J Urol 175: 2006.
45. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. J Urol 175: 348, 2006.
46. I. Leibovitch., R. Rona, S, Lew,. I. Sternberg The significance of suspicious urine cytology (class III) in the management of bladder cancer. J Urol 177: 361, 2007 .
47. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I. Combined analysis of morphology and fluorescence in situ hybridization for increased accuracy of cancer diagnosis CANCER CYTOPATHOLOGY: 111( 5): 444 (Abstract 149) 2007
48. A. Hochberg; AA. Sidi; B Shalva, I Leibovitch; M Shalev P Ohana
Patient-Oriented DNA-Based Drug for Bladder Cancer Human Gene Therapy 18 (10): 951, 2007
49. AA Sidi, B Shalva, I Leibovitch, M Shalev, A Hochberg, P Ohana
Phase 1/2a, dose-escalation, safety and efficacy of intravesical plasmid (BC-819) in patients with superficial transitional cell cancer of the bladder (STCCB) J Urol 179(4):613, 2008
50. Sternberg, I Kafka, I Vardi, I Leibovitch, I Stone volume-a predictor of spontaneous ureteral stone passage J ENDOUROL 23: A84, 2009
51. Ramon J, Dotan Z, Darawsha AE, Leibovitch I DNA methylation-based urine assay for detection and monitoring of bladder cancer. J Urology,. 191: e239, 2014
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
52. Darawsha AE Fishelevitz A, Pomerantz A, Leibovitch I and Neheman A
Nocturnal enuresis by age group - characteristics and response to treatment J Pediatric Urology 2015
53. Darawsha AE Sterenberg I Leibovitch I and Neheman A Evaluation of subjective and objective improvement after meatotomy- long term follow up J Pediatric Urology 2015
54. Yossepowitch, O Mor, Y Nativ, O Leibovitch, I Gofrit, O Matzkin, H; Lindner, U Sidi, A ; Cohen, M A novel urine cytology stain for the detection and monitoring of urothelial carcinoma J Urology: 193 (4) E481-E481 2015
55. Davis, N Lew, S Rona, R Shtabsky, A Mor, Y Lindner, U Nativ, ;Leibovitch,
I Sidi, A Cohen, M | Combining color and morphology improves identification of low-grade urothelial cancer cells VIRCHOWS ARCHIV Supplement: 1 467: S8-S8 2015
56. Levi A Vainrib M Leibovitch I Could non-invasive uroflowmetry parameters change the diagnosis of bladder outlet obstruction in male patients? Neurourology and Urodynamics 33: (6) 905 2014
E. ITEMS IN ENCYCLOPEDIAS
F. BOOKS EDITED
G. OTHER PUBLICATIONS (Encyclopedias; Reports; Letter to Editors)
G.1 LETTERS
, ב. גולדווסר.א. ליבוביץ. 1 גנר.מעורבות בלוטת הערמונית בגרגירומת ו
1989 ,348-349 :117. הרפואה I. Leibovitch, B. Goldwasser.
Prostatic involvement in Wegener's granulomatosis. Harefuah. 117: 348-9, 1989
2. I. Leibovitch
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
Hydronephrosis as a prognostic indicator in bladder cancer patients. J. Urol. 162: 808 (Pt 1),1999.
3. I. Leibovitch Ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma. Urology.54:193-194, 1999.
א. ליבוביץ .4
האתגר: אבחנה וטיפול בכאב אשך כרוני. 119:114, 1111. הרפואה
I. Leibovitch The challenge:the diagnosis and management of chronic orchalgia Harefua 136: 914, 1999.
, י. מור, ה. וינקלר, י. גולומב, י. רמון.א. ליבוביץ .0
בחדר המיון של מרכז רפואי גדול בישראל: היבטים הוריות לאישפוז חולי קדדת הכליות קליניים.–אפידמיולוגים
551:,31::145הרפואה.
I. Leibovitch, Y. Mor, H. Winckler, J. Golomb, J. Ramon. RE: Indications for hospitalization of renal colic patients in the emergency room of a large medical center in Israel: Epidemiological and clinical implications.
Harefua 140: 283, 2001. 6. Leibovitch I.
Incidence and management of gynecomastia in men treated for prostate cancer J Urol. 175:1963, 2006.
6. Leibovitch I.
Percutaneous renal biopsy. Harefua 145: 546, 2006
7. Leibovitch I. Blood loss duringretropubic radical prostatectomy. Harefua 145: 547 2006.
G.2 BOOKS
א. ליבוביץ. 1
פרוסטטה ובעיות אחרות הקשורות לערמונית. (BOOK. )1111פרולוג מוציאים לאור בע"מ. ראש העין, ישראל
I. Leibovitch Prostate Prolog Publishers Ltd. Rosh Haain, Israel, 1997.
Name: ILAN LEIBOVITCH Degree MD CV updated JAN 2017
שדה חובה*
א. ליבוביץ . :
הזרימה חייבת להמשך–פרוסטטה (BOOK. )554:פרולוג מוציאים לאור בע"מ. ראש העין, ישראל
I. Leibovitch Prostate-the flow must go on Prolog Publishers Ltd. Rosh Haain, Israel, 2004.
H. Member of Editorial Board/ Reviewer (International Journals)